Quick-Med Technologies’ Research & Development Center Moves to New Location
Expanding its Research & Development Center in Gainesville
Gainesville, FL, February 14, 2008 --(PR.com)-- Quick-Med Technologies, Inc. (OTCBB: QMDT) announced today that its Research & Development Center has moved to a new location in Gainesville, Florida. The new space, for which it has a 3-year lease, will offer larger on-site testing facilities to better service the needs of its customers and partners.
Announcing the move, Quick-Med Technologies’ Vice President of R&D and Commercialization, Dr. Gerald M. Olderman, commented: “The new larger facility is close to the University of Florida, a working partner in the company’s two core technologies, and will provide us with an excellent base to service both our current and planned future growth. We look forward to a faster pace of R&D now that we have the appropriate space.”
Located in close proximity to downtown and its licensor, the University of Florida at Gainesville, the Research & Development Center has settled nicely into its new surroundings. The new address and phone number are as follows:
Quick-Med Technologies, Inc
Research & Development Center
904 NW 4th Street
Gainesville, Florida 32601-4285
Tel. (352) 379.0611
Fax (352) 379.1099
About Quick-Med Technologies, Inc.
Quick-Med Technologies, Inc. is a life sciences company that is developing broad-based technologies for the healthcare and consumer markets. The Company's two core product groups under development are (1) NIMBUS®, a technology employing advanced polymers that can be used in a wide range of applications from advanced wound care to industrial and consumer products; and (2) MultiStat™ family of advanced patented methods and compounds, shown to be effective in key skin care therapy applications for cosmetic, military, and medical markets. For more information, see: www.quickmedtech.com.
Contact:
Natasha A. Sorobey, Investor & Media Relations
Tel. (888) 835.2211 Ext 107
Email: natasha.sorobey@quickmed-inc.com
Safe Harbor for Forward-Looking Statements
Certain statements contained in this press release may be deemed to be forward-looking statements under federal securities laws, and Quick-Med Technologies, Inc. intends that such forward looking statements be subject to the safe harbor created thereby. Quick-Med Technologies, Inc. does not undertake an obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
###
Announcing the move, Quick-Med Technologies’ Vice President of R&D and Commercialization, Dr. Gerald M. Olderman, commented: “The new larger facility is close to the University of Florida, a working partner in the company’s two core technologies, and will provide us with an excellent base to service both our current and planned future growth. We look forward to a faster pace of R&D now that we have the appropriate space.”
Located in close proximity to downtown and its licensor, the University of Florida at Gainesville, the Research & Development Center has settled nicely into its new surroundings. The new address and phone number are as follows:
Quick-Med Technologies, Inc
Research & Development Center
904 NW 4th Street
Gainesville, Florida 32601-4285
Tel. (352) 379.0611
Fax (352) 379.1099
About Quick-Med Technologies, Inc.
Quick-Med Technologies, Inc. is a life sciences company that is developing broad-based technologies for the healthcare and consumer markets. The Company's two core product groups under development are (1) NIMBUS®, a technology employing advanced polymers that can be used in a wide range of applications from advanced wound care to industrial and consumer products; and (2) MultiStat™ family of advanced patented methods and compounds, shown to be effective in key skin care therapy applications for cosmetic, military, and medical markets. For more information, see: www.quickmedtech.com.
Contact:
Natasha A. Sorobey, Investor & Media Relations
Tel. (888) 835.2211 Ext 107
Email: natasha.sorobey@quickmed-inc.com
Safe Harbor for Forward-Looking Statements
Certain statements contained in this press release may be deemed to be forward-looking statements under federal securities laws, and Quick-Med Technologies, Inc. intends that such forward looking statements be subject to the safe harbor created thereby. Quick-Med Technologies, Inc. does not undertake an obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
###
Contact
Quick-Med Technologies, Inc.
Natasha Sorobey
888.835.2211
www.quickmedtech.com
Natasha Sorobey
888.835.2211
www.quickmedtech.com
Contact
Categories